Home » Newsletters » BioWorld Science

BioWorld Science

July 24, 2017

View Archived Issues

EMA's CHMP grants positive opinion for dupixent for the treatment of atopic dermatitis

FDA grants clearance to first neonatal magnetic resonance imaging device

DNA vaccines targeting alpha-synuclein show promise for the treatment of dementia

EMA committee backs approval of Janssen's Symtuza

FDA gives orphan drug exclusivity to CSL Behring's Haegarda

FDA approves new self-injectable formulation of Benlysta

FDA awards fast track designation to Valneva's Lyme disease vaccine candidate VLA-15

AbbVie's Humira receives positive opinion from EMA for uveitis

Phase I PK/PD data presented for Eisai's PDE9A inhibitor E-2027

Lutathera receives positive opinion from EMA for GEP-NETs

GSK and Innoviva seek E.U. approval of extended use of Relvar Ellipta

Chugai files for Japanese approval of emicizumab in hemophilia A

ORIC Pharmaceuticals presents glucocorticoid receptor antagonists

Council of Scientific and Industrial Research divulges compounds for vitiligo treatment

CHMP supports approval of Novartis' Rydapt in E.U.

Chiesi Farmaceutici discloses MAPK14 inhibitors

Xermelo obtains positive opinion from EMA committee

NeuroDerm to be acquired by Mitsubishi Tanabe Pharma

Cancer Research Technology discovers TTK inhibitors

CHMP grants positive opinion for Keytruda in urothelial carcinoma

Sichuan Haisco Pharmaceutical discovers compounds for asthma treatment

CHMP recommends approval of avelumab for metastatic Merkel cell carcinoma

CHMP issues negative opinion on Vanda Pharmaceuticals' Fanaptum

EMA committee issues new Day 180 list of outstanding issues for abaloparatide

Tissue Regenix to acquire CellRight Technologies

Identified a rare variant in ADAM17 gene tied to familial Alzheimer's disease

EMA's CHMP recommends approval of Gazyvaro for previously untreated advanced follicular lymphoma

EMA committee recommends approvals for Tecentriq in NSCLC and metastatic urothelial carcinoma

RoActemra recommended for approval in E.U. for giant cell arteritis

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...